F. Hoffmann-La Roche´Â ⸳ÀÚÀÎ Fritz Hoffmann-La Roche¿¡ ÀÇÇØ 1896³â ½ºÀ§½ºÀÇ Basel¿¡¼ ⸳ÇÑ 110¿© ³âÀÇ ¿ª»ç¸¦ °¡Áø ¼¼°èÀû Health Care ±×·ìÀÔ´Ï´Ù.
·Î½´±×·ìÀº Á¦¾à°ú Áø´ÜÀ» ±× ÇÙ½É »ç¾÷À¸·Î ÇÏ°í ÀÖÀ¸¸ç ÇöÀç Àü¼¼°è 150¿© °³±¹¿¡¼ 80,000¿©¸íÀÇ Á÷¿øµéÀÌ ´Ù¾çÇÑ ºÐ¾ß¿¡¼ ±Ù¹«ÇÏ°í ÀÖ½À´Ï´Ù. ·Î½´ ±×·ìÀÇ ÇÙ½É »ç¾÷ºÐ¾ß Áß ÇÑ ºÎºÐÀÎ ·Î½´Áø´ÜÀº 1968³â ¼³¸³ÇÑ ÀÌÈÄ¿¡ Çõ½ÅÀûÀÎ Á¦Ç°°ú ½Å±â¼ú·Î Àü¼¼°è ü¿Ü Áø´Ü¾÷°èÀÇ ¸®´õ·Î¼ÀÇ À§Ä¡¸¦ ±»°ÇÈ÷ ÇÏ°í ÀÖ´Â Áø´Ü¿ë ÀÇ·á±â±â ¹× ½Ã¾à Àü¹®È¸»çÀÔ´Ï´Ù.
·Î½´Áø´ÜÀÇ ±¹³» ÇöÁö ¹ýÀÎÀÎ Çѱ¹·Î½´Áø´ÜÀº Áø´Ü°Ë»çÀÇÇÐ(Centralized Diagnostics), ȯÀÚ°ç°Ë»ç(Near Patient Testing), ºÐÀÚÁø´Ü(Molecular Diagnostics), »ý¸í°úÇÐ(Applied Science), ´ç´¢Áø´Ü(Diabetes Care), Á¶Á÷º´¸®ºÐ¾ß(Tissue-based Diagnostics)ÀÇ Áø´Ü»ç¾÷ºÎ·Î ÀÌ·ç¾îÁ® ÀÖÀ¸¸ç ±¹³» Áø´Ü½Ã¾à¾÷°èÀÇ Primary Company·Î½á ±¹³» Áø´Ü¾÷°èÀÇ ¹ßÀü°ú ¼ºÀå¿¡ Å« ±â¿©¸¦ ÇÏ°í ÀÖ½À´Ï´Ù.
Á÷¾÷Á¤º¸Á¦°ø»ç¾÷½Å°í¹øÈ£ J150002023003